MPLT MapLight Therapeutics, Inc.

NASDAQ
$6.93

MapLight Therapeutics, Inc. (MPLT) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Bullish Insiders bought more than they sold over this window — uncommon at any size.
Cluster activity 0 buyers in the last 30 days 1 buyer in the last 90 days 6 sellers in the last 90 days
Insiders buying
1
1 transaction
Insiders selling
6
7 transactions
Purchases
$50.1M
4,400,000 shares
Sales
$1.3M
148,503 shares
Net activity
$48.8M
purchases less sales

How much of that selling was preplanned? 15% planned / 85% discretionary

10b5-1 plan sales $192.7K 1 transaction · 16,509 shares
Discretionary sales $1.1M 6 transactions · 131,994 shares

Largest single sale: $595.4K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: August 14, 2026 , by Catalyst4, Inc. .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Kroeger Christopher A. Chief Executive Officer Sell 73,691 $8.08 $595.4K 1,195,909 −5.8% of holding
Foff Erin Pennock Chief Medical Officer Sell 15,355 $8.08 $124.1K 296,906 −4.9% of holding
Kreitzer Anatol Chief Discovery Officer Sell 12,248 $7.84 $96.0K 168,678 −6.8% of holding
Lillie James Woodruff Chief Scientific Officer Sell 11,513 $8.08 $93.0K 198,597 −5.5% of holding
GILLIS JONATHAN CAO and Interim CFO Sell 10,167 $8.08 $82.1K 142,315 −6.7% of holding
Hanson Kristopher General Counsel Sell 9,020 $8.08 $72.9K 128,024 −6.6% of holding
Hanson Kristopher General Counsel Sell 10b5-1 16,509 $11.67 $192.7K 137,044 −10.8% of holding
Catalyst4, Inc. 10% Owner Buy 4,400,000 $11.38 $50.1M 25,306,689

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.